A Cochrane review pooled nine trials of regulated medical cannabis for insomnia, covering 537 adults aged 18 to 76, and found ...

Commentary: Senior-care facilities are expanding services beyond their walls and bringing them into the community and directly into homes.

FDA approves Bayer’s asundexian (Sunharbo), the first Factor XIa inhibitor, for secondary stroke prevention. FDA has granted ...

Zero HIV Acquisitions Occurred Among Participants Receiving Twice-Yearly Lenacapavir During the 52-Week Study Period – – ...

Certain handwriting features, such as writing efficiency and coordination, may shed light on the cognitive health of older ...

Foundayo ™ (fown-DAY-oh) is a prescription medicine used with a reduced-calorie diet and increased physical activity to help ...

Bayer has secured US FDA marketing approval for Sunharbo (asundexian), tablets, marking a major milestone in stroke ...

These are the gifts we've tried, tested, and loved this year — and the gifts on our own personal wishlists.

From serving our nation to caring for patients across the Rio Grande Valley, nearly 100 veterans employed throughout South ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, ...